Cargando…
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC
SIMPLE SUMMARY: Biomarkers to guide clinical decisions and efficacy are limited in advanced non-small cell lung cancer’s anti-PD-1 immune checkpoint inhibitors. We prospectively explored baseline peripheral blood mononuclear cells in order to asses’ immunotherapy predictors in this setting. We inclu...
Autores principales: | Rogado, Jacobo, Pozo, Fernando, Troule, Kevin, Sánchez-Torres, José Miguel, Romero-Laorden, Nuria, Mondejar, Rebeca, Donnay, Olga, Ballesteros, Anabel, Pacheco-Barcia, Vilma, Aspa, Javier, Al-Shahrour, Fátima, Alfranca, Arantzazu, Colomer, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221141/ https://www.ncbi.nlm.nih.gov/pubmed/35740564 http://dx.doi.org/10.3390/cancers14122898 |
Ejemplares similares
-
Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies
por: Rogado, Jacobo, et al.
Publicado: (2020) -
When should we order a next generation sequencing test in a patient with cancer?
por: Colomer, Ramon, et al.
Publicado: (2020) -
The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair
por: Pacheco-Barcia, Vilma, et al.
Publicado: (2022) -
Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer
por: Esparcia-Pinedo, Laura, et al.
Publicado: (2023) -
Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome
por: Gómez-León, Nieves, et al.
Publicado: (2018)